Representative images of PIM1 positivity in NSCLC tissue is shown in Figure 1B. Overall PIM1 positive patients (i.e., those with an Allred score of ≥3) had a median survival time of 23.67 months in comparison to 37.32 months in the PIM1 negative group (n = 134, Log-rank test p = 0.056) (Figure 1C). The gene discussed is PIM1; the disease is non-small cell lung carcinoma.